Minimal Residual Disease Models to Evaluate the Optimal Dose and Timing of MEK Inhibitor Treatment for NeuroblastomaYuichi Togashi,Yuki Takeuchi,Mayumi Higashi,Shigehisa Fumino,Tatsuro TajiriPEDIATRIC BLOOD & CANCER(2018)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要